Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares Issued
Ratios

Maxcyte (MXCT) Leases (2020 - 2025)

Maxcyte (MXCT) has disclosed Leases for 6 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • Quarterly Leases rose 1.43% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2025, up 1.43% year-over-year, with the annual reading at $10.9 million for FY2025, 1.43% up from the prior year.
  • Leases for Q4 2025 was $10.9 million at Maxcyte, down from $11.1 million in the prior quarter.
  • The five-year high for Leases was $11.5 million in Q1 2025, with the low at $1.0 million in Q3 2021.
  • Average Leases over 5 years is $9.4 million, with a median of $10.8 million recorded in 2024.
  • The sharpest move saw Leases skyrocketed 2506.18% in 2021, then fell 10.5% in 2023.
  • Over 5 years, Leases stood at $5.7 million in 2021, then soared by 73.18% to $9.9 million in 2022, then rose by 14.09% to $11.2 million in 2023, then dropped by 4.23% to $10.8 million in 2024, then grew by 1.43% to $10.9 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $10.9 million, $11.1 million, and $11.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.